Wednesday, July 8, 2026

pharma · NASH With Fibrosis · NASH - Nonalcoholic Steatohepatitis · HEPA

Hepion Pharmaceuticals

Hepion Pharmaceuticals clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Morristown, USA HQ
4 Employees
Public company Type
HEPA · NYSE Ticker
Company details
Status
Public
HQ
Morristown, USA
Employees
4
Programs
5
Drugs
2
Patents
1
Intelligence · Clinical Programs

Hepion Pharmaceuticals projects

0 ClinicalTrials.gov programs sponsored by Hepion Pharmaceuticals.

Hepion Pharmaceuticals has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Hepion Pharmaceuticals have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.